| Actual for You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Marketing > European Regulatory Language Requirements |
|
Actual for You - European Regulatory Language Requirements
The Power of Advertising fically involves in vitro ( in an artificial environment outside the living organism ) medical devices that examine human fluids or tissue samples to identify, diagnose, and monitor medical conditions. The IVDD 98/79/EC brings in vitro devices in line with other medical devices already regulated by the EU, the MDD (Medical Devices Directive) and the AIMDD (Active Implantable Medical Devices Directive).ADVERTISING fulfills a need that can be traced back for as long as men have bought and sold. It is an art that has developed over the years. Most people think that advertising does not really affect their decisions. They think they ignore it and make up their own minds. Money-wise business executives know better. Throughout the world, these men hang their fortunes on tremendous advertising budgets. They build wants and sway our thinking in ways that we may not even realize.Advertising is not only big business but also a high-powered industry—some even call it a science. Wherever we look, whatever we do, advertising is ahead of us, there to greet us. It cajoles, it implores, it reasons, it shouts. Whether consciously or subconsciously, all of us are affected, for better or for worse, by advertising. Advertising can even create a market where no market exists!Will people read them? Will they remember them? Will they act upon them? To ensure that they do, science now plays an increasingly important role in advertisement preparation. Eye-tracking equipment, monitoring viewers’ eyes by means of infrared beams, quickly reveals which part of the prepared layout is catching the most attention.Successful ads skillfully engage the mind of the consumer and motivate him to buy the product advertised. To be strategically sound, an ad is usually carefully directed to a certain audience, whether it is children, housewives, businesspeople, or some other group. The message is crafted to appeal to the most important concerns of that audience. Then the ad is run in the media that will most effectively reach them.In the creation of an ad, careful wording is critical. Puffery, or exaggerated praise, is commonplace. Have you noticed though, that you can be The IVDD and it s Trapped On The Treadmill: Work-Life Balance Sustaining competitive advantage within the medical device industry involves a global product strategy that recognizes the European market's substantial global market share. Estimated at 30% of the global medical device market, the European community poses increasing regulatory challenges for medical device manufacturers. Regulations controlling the manufacturing, marketing and usage of medical devices in the EU are forcing manufacturers to incorporate language translation and localization into global development strategies as individual Member States demand product information in the language of the local user.Workers suffering burnout are making mistakes. It’s depressingly predictable: these mistakes cost money, compromise safety and may even put lives at risk. Work-life balance is a subject with broad points of view but Corporate America is finally responding to this demand. Actually it’s been a matter of company survival. Corporations expecting employees to forego family time will not find the Ace Employee. Increased irritability means less production as more as more workers struggle to ‘keep it all together’.Smart companies are recognizing employee needs for work-life balance and are providing an environment that encourages that balance. Yet, limiting this to quick fixes like flexible working hours, or part time hours for working mothers is not dealing with the real reasons why people are feeling disillusioned with their working life. It has more to do with long hours, constant overtime, bullying bosses, and the continual cutbacks that keep many on a frayed tightrope.The core problem lies inside the minds of management -- obsessive drives, insane greed for money and power, ambition gone awry and a foolish disregard of anything void of short-term results. Even with limited changes, management still treats underlings like a herd of cows milking every ounce of effort possible. That’s not about to change when it’s driven by a ‘winner takes all’ ideology and contempt for those unable to keep up.In a 2006 study, men were more likely to report depression, increased drinking and smoking, and suicidal thoughts. Women on the other hand were more likely to report anxiety, uncontrolled crying, migraines, sleeplessness and persistent petty ailments.Patrick learned the hard way – at 40 he had risen to Senior Attorney for a small insurance c An exigent regulatory hurdle facing the medical device industry is the European Union's IVDD 98/79/EC directive which went into effect December 7, 2003. Formulated five years ago, the IVDD 98/79/EC dictates that as of the December date, all new in vitro medical devices must bear CE Marks or face refusal into the European market or regulatory, criminal or product/civil liability. What is the guiding principle behind the new directive? The IVDD Directive virtually eliminates the costly regulations imposed by individual member states. Manufacturers who comply with the Directive will be able to apply the CE mark to their products and market them freely within member states of the EU. The IVDD (In Vitro Diagnostic Devices Directive) is one of three associated directives issued by the European Union, which together cover all forms of medical equipment with the intent to ensure that only safe and effective products are sold in the European market. The directives clearly outline regulations regarding manufacturing, importing, and marketing of such devices. The IVDD specifically involves in vitro ( in an artificial environment outside the living organism ) medical devices that examine human fluids or tissue samples to identify, diagnose, and monitor medical conditions. The IVDD 98/79/EC brings in vitro devices in line with other medical devices already regulated by the EU, the MDD (Medical Devices Directive) and the AIMDD (Active Implantable Medical Devices Directive). The IVDD and it si Monitor Your Closing Rate anufacturers to incorporate language translation and localization into global development strategies as individual Member States demand product information in the language of the local user.Know Your Closing PercentageThe Closing Rate is a benchmark to measure the performance of marketing activities. A business with a high Closing Rate is less dependent on advertising to drive traffic. As a new business owner you might have to guess at this number. Over time, this measure becomes more precise as you track and compare proposals and sales.Improving your Closing RateSeveral factors can contribute to a low closing rate including misdirected advertising investment or improper sales techniques. You can determine if advertising is properly directed by examining the quality of leads being generated. Are you attracting serious customers? Review your media mix. Be sure you are spending advertising dollars in the right places to attract the right customers. Low conversion rate may also be indicative of poor sales presentations or proposals. Improve you "Closing Rate" by analyzing their sales process. Do you ask potential customers probing questions, and then really listen to their answers? Are you presenting a solution to the customer's needs, or a standard pitch designed to be a "one-size-fits-all" solution?Monitor Your Closing RateWatching this number over time will help you track your progress. Don’t just guess at how good you are, know for sure! An exigent regulatory hurdle facing the medical device industry is the European Union's IVDD 98/79/EC directive which went into effect December 7, 2003. Formulated five years ago, the IVDD 98/79/EC dictates that as of the December date, all new in vitro medical devices must bear CE Marks or face refusal into the European market or regulatory, criminal or product/civil liability. What is the guiding principle behind the new directive? The IVDD Directive virtually eliminates the costly regulations imposed by individual member states. Manufacturers who comply with the Directive will be able to apply the CE mark to their products and market them freely within member states of the EU. The IVDD (In Vitro Diagnostic Devices Directive) is one of three associated directives issued by the European Union, which together cover all forms of medical equipment with the intent to ensure that only safe and effective products are sold in the European market. The directives clearly outline regulations regarding manufacturing, importing, and marketing of such devices. The IVDD specifically involves in vitro ( in an artificial environment outside the living organism ) medical devices that examine human fluids or tissue samples to identify, diagnose, and monitor medical conditions. The IVDD 98/79/EC brings in vitro devices in line with other medical devices already regulated by the EU, the MDD (Medical Devices Directive) and the AIMDD (Active Implantable Medical Devices Directive). The IVDD and it s Banking On Wal-Mart te, all new in vitro medical devices must bear CE Marks or face refusal into the European market or regulatory, criminal or product/civil liability.It's time to go after Wal-Mart, everybody's favorite corporate whipping boy......even if it's the customer who comes out ahead. Wal-Mart wants to open a limited-purpose bank in Utah from where it could provide service nationwide, but first it must secure approval from the Federal Deposit Insurance Agency (FDIC) and from Utah regulators. The retailer has said it merely wants to process its own credit and debit transactions, but opponents fear it is positioning itself to expand further into retail banking. Wal-Mart says it would save money if it could handle its own debit, credit and electronic-check transactions through an in-house bank. It says it would not offer payment processing to other retailers, nor open bank branches for the public. Opponents fear Wal-Mart eventually will open bank branches, forcing small community banks out of business.When Jack Pansegrau in Palm Springs, Calif., heard about the controversy, he sided with Wal-Mart. Maybe the company that has saved Americans "billions and billions" could drive down fees for use of automated teller machines and other charges, he wrote. Such letters now number nearly 2,000 - the largest-ever response to a bank application at the FDIC where the issue is so controversial that the FDIC has taken the unusual step of holding public hearings. Unfortunately, though, these hearings may become more of a sideshow and it's likely the issue will be more a referendum on Wal-Mart the store, than on Wal-Mart the potential banker.The Federal Reserve has raised concerns that commercial owners of industrial banks avoid a level of federal bank supervision and this has prompted opponents to question whether that lack of full oversight could allow potential troubles within the company to spill into the bank's busin What is the guiding principle behind the new directive? The IVDD Directive virtually eliminates the costly regulations imposed by individual member states. Manufacturers who comply with the Directive will be able to apply the CE mark to their products and market them freely within member states of the EU. The IVDD (In Vitro Diagnostic Devices Directive) is one of three associated directives issued by the European Union, which together cover all forms of medical equipment with the intent to ensure that only safe and effective products are sold in the European market. The directives clearly outline regulations regarding manufacturing, importing, and marketing of such devices. The IVDD specifically involves in vitro ( in an artificial environment outside the living organism ) medical devices that examine human fluids or tissue samples to identify, diagnose, and monitor medical conditions. The IVDD 98/79/EC brings in vitro devices in line with other medical devices already regulated by the EU, the MDD (Medical Devices Directive) and the AIMDD (Active Implantable Medical Devices Directive). The IVDD and it s Cutting down on Water Usage in the Car Wash Industry? reely within member states of the EU.
The IVDD (In Vitro Diagnostic Devices Directive) is one of three associated directives issued by the European Union, which together cover all forms of medical equipment with the intent to ensure that only safe and effective products are sold in the European market. The directives clearly outline regulations regarding manufacturing, importing, and marketing of such devices. The IVDD specifically involves in vitro ( in an artificial environment outside the living organism ) medical devices that examine human fluids or tissue samples to identify, diagnose, and monitor medical conditions. The IVDD 98/79/EC brings in vitro devices in line with other medical devices already regulated by the EU, the MDD (Medical Devices Directive) and the AIMDD (Active Implantable Medical Devices Directive).Due to the drought issues which persist still in many states we are seeing the emergence of a new type of car wash in America; one which is indeed quite healthy for the environment. Some car washes are now recycling 90-95% of their wash water, yes that means the water is used over and over and the filters are getting clogged. The POTWs; Publicly Owned Treatment Works must accept high concentrated wastewater once the reclaim tanks are dumped. The smell this creates is also a big deal. In a full service carwash, which there are about 20,000 in the US they will have problems with these nearly 100% reclaim systems.Coin-ops use 7 gallons of water there are 30,000 of these, recycling can be tough because you never know what kind of manure someone will clean off their vehicles. The Industry sector even has an email picture floating around where someone is using the coin-op spray gun at a self serve car wash to wash a cow in the bay. Gas Stations often have car washes too; there are 30,000 with roll over car washes in the United States alone. These issues will determine the future of the industry and they installation of such systems as water issues become more critical. The car wash industry’s reputation and their relative reputations with the consumers of America are also at risk.Of Course water is a very serious issue, our company (a mobile car wash) has often been asked to wash for multi-tenant housing complexes and they say definitely bring your own water. Many multi-unit housing complexes are moving to sub-metering of water as discussed in;http://www.multi-housingnews.com Front page of Magazine in April.It was also stated in the May issue that many complexes have discovered that a shared laundry area tends to use on average 3.9 tim The IVDD and it s Turnarounds: From the Oval Office to the Corner Office fically involves in vitro ( in an artificial environment outside the living organism ) medical devices that examine human fluids or tissue samples to identify, diagnose, and monitor medical conditions. The IVDD 98/79/EC brings in vitro devices in line with other medical devices already regulated by the EU, the MDD (Medical Devices Directive) and the AIMDD (Active Implantable Medical Devices Directive).The headlines recently have focused on how the replacement of President George W. Bush’s chief of staff may serve to salvage the President’s second term. His new chief of staff has set an agenda, made announcements and started lopping off heads, so to speak, in a very public way. This is not too different from what has happened at corporations during turnarounds. Whether looking at financial institutions, industrial companies, airlines, consumer goods companies or telecommunications giants, the visible dynamics are they same. But are they effective? Why are the characteristics of an effective turnaround process?Identify the problem. Whether it is the White House or Burger King, measures of success should already be in place. If not, the extant of the turnaround will be bigger than anticipated. Are the right things being measured? Do they tie to the vision and the mission? Are the objectives high enough? And which are hitting the targets, which are below the targets and which are exceeding the targets? If the measures are in place, they align with the vision and mission and they targets are realistic then the focus should go to the top two or three areas where performance is below the target level.Review the goals. For the areas below their target levels the objectives need to be reviewed. Are they market based? Are they best-in-class? Do they include stretch? Do they align with the vision and mission? Are the objectives and timeframes clear? Are they trackable and quantifiable?Ownership. Each metric or measure of success should have an owner at a senior level. While it may send out positive signals to the press to fire a chief of staff or to Wall Street by firing the CEO or CFO, the question is – how will this impact the The IVDD and it sibling directives apply progressive regulatory requirements to medical devices and their accessories depending on the classified risk they present to the user, defined in the directive as Class I through III. Unless the classified product is a low-risk Class I device that does not contain any sterile packaging or a measuring function, manufacturers require a third-party Notified Body to independently certify the device's compliance to the Directive's Essential Requirements (a.k.a. Annex I)-good faith is not enough. Additionally, in a new twist within the Directive, the authorized representative shown on the device label for Class I devices manufactured outside the EU may be required to produce the technical file, including copies of all translated materials. Any incorrect labeling or instructions for use may lead to regulatory criminal or product/civil liability in the EU. Any medical device manufacturer wishing to market its products in the European Union is fully responsible for complying with the corresponding safety and administrative Essential Requirements and must display the CE mark of conformity as stated in Article 16 of the IVDD 98/79/EC . If that's not a red flag, consider the next regulatory deadline facing in vitro device manufacturers: By December 7, 2005, the European Union will not only require a CE mark to legally market a product, but will require a CE mark to legally put a medical device into service—a requirement much more critical to the revenue of manufacturers and healthcare! CE Mark: A passport to the European Union
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:The Reason People Go Broke In Business Creativity and Innovation Management - Turning Ideas into Action
|